Clinical Trial Update: Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the Treatment Benefit Questionnaire in chronic migraine patients treated with BOTOX (onabotulinumtoxinA); results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Chronic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2015-10-21